Clinical benefits of diagnosing incipient AA amyloidosis in pediatric rheumatic diseases as estimated from a retrospective study

Amyloid

Volumn 5, Issue 3, 1998, Pages 200-207

  Michels, Hartmut ^a   Linke, Reinhold P ^b  

^a Rheumatic Children's Hospital   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Amyloidosis; Diagnostic errors; Familial Mediterranean fever; Health expenditures; Immunohistochemistry; Juvenile rheumatoid arthritis

Indexed keywords

SERUM AMYLOID A;

AMYLOIDOSIS; ARTICLE; BIOPSY; CASE REPORT; CHILD; EPIDEMIOLOGY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; INFANT; INFORMATION CENTER; JUVENILE RHEUMATOID ARTHRITIS; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TIME;

AMYLOIDOSIS; ARCHIVES; ARTHRITIS, JUVENILE RHEUMATOID; BIOPSY; CAUSALITY; CHILD; CHILD, PRESCHOOL; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SERUM AMYLOID A PROTEIN; TIME FACTORS;

EID: 0032150740     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129809003846     Document Type: Article

References (26)

1. Strauss RG. Schubert WK. and McAdams AJ (1969). Amyloidosis in childhood. J Pediatr. 74, 272-282
2. Trainin EB, Spitzer A and Greifer I (1978). Amyloidosis in juvenile rheumatoid arthritis. New York State Journal of Medicine, 1, 72-77
3. Ludomirsky A, Passwell J and Boichis H (1981). Amyloidosis in children with familial Mediterranean fever. Arch Dis Child, 56, 464-467
4. Zemer D, Livneh A, Danon Y, Pras M and Sohar E (1991). Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum, 34, 973-977
5. Woo P (1994). Amyloidosis in children. Baillière's Clin Rheumatol, 8, 691-697
6. Ben-Chetrit E and Levy M (1991). Colchicine prophylaxis in familial Mediterranean fever: Reappraisal after 15 years. Sem Arthritis Rheum, 20, 241-246
7. Schnitzer TJ and Ansell BM (1977). Amyloidosis in juvenile chronic polyarthritis. Arthritis Rheum, 20 (Suppl.), 245-252
8. David J, Vouyiouka O, Ansell BM, Hall A and Woo P (1993). Amyloidosis in juvenile chronic arthritis: A morbidity and mortality study. Clin Exp Rheumatol, 11, 85-90
9. Levy M, Prieur AM, Gubler M, Hayem F, Manigne P, Cheron G and Niaudet P (1987). Renal involvement in juvenile chronic arthritis: Clinical and pathologic features. Am J Kidney Dis, 9, 138-146
10. Schuchmann L, Michels H, Renaud M and Renz K (1981). Die Amyloidose - eine gefürchtete Folgekrankheit der juvenilen chronischen Arthritis (JCA). Klinische Pädiatrie, 193, 67-72
11. Hawkins PN, Richardson S, Vigushin DM, David J, Kelsey CR, Gray RES, Hall MA, Woo P, Lavender JP and Pepys MB (1993). Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum, 26, 842-851
12. Linke RP, Gärtner H-V and Michels H (1995). High sensitivity diagnosis of amyloidosis using Congo red and immunohistochemistry detects missed amyloid deposits. J Histochem Cytochem, 43, 863-869
13. Puchtler H, Sweat F and Levine M (1962). On the binding of Congo red by amyloid. J Histochem Cytochem, 10, 355-364
14. Sternberger LA (1979). Immunohistochemistry, (Wiley, New York)
15. Michels H and Linke RP (1993). Subcutaneous fat biopsy - suitable as a screening investigation for AA amyloidosis in childhood? Rev Esp Reumatol, 20, 368
16. Falck HM, Törnroth T, Skrifvars B and Wegelius O (1979). Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand, 205, 651-656
17. Cusano AJ, Bland JH, Lapenas DJ, Cohen AS and Libbey C (1982). Juvenile rheumatoid arthritis with renal amyloidosis: A 23-year survival. J Rheumatol, 9, 921-925
18. Perez-Villa F, Campistol JM, Ferrando J and Botey A (1989). Renal amyloidosis secondary to acne conglobata. Int J Dermatol, 28, 132-133
19. Escalante A, Ehresmann GR and Quismorio FP Jr. (1991). Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Arthritis Rheum, 34, 920-922
20. Gertz MA and Kyle RA (1994). Amyloidosis: prognosis and treatment. Sem Arthritis Rheum, 24, 124-138
21. Michels H and Linke RP (1996). Development of amyloidosis as an unrecognized side effect of gold therapy: comment on the article by Shapiro and Spiera. Arthritis Rheum, 39, 1932-1933
22. Michels H, Donini U and Linke RP (1994). Resolution of AA amyloidosis in juvenile rheumatoid arthritis (JRA) as shown with computer-aided quantitation of amyloid. In Kisilevsky R. Benson M, Frangione B, Gauldie J, Muckle T and Young I (eds.) Amyloid and Amyloidosis 1993, pp. 694-696. (The Parthenon Publishing Group Ltd. Casterton Hall)
23. McSweeney PA, Nash RA, Storb R, Furst DE, Gauthier J and Sullivan KM (1997). Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. J Rheumatol, 24 (Suppl.48), 79-84
24. Martini A, Maccario R, Ravelli A, Montagna D, De Benedetti F, Bonetti F, Viola S, Zecca M, De Stefano P and Locatelli F (1997). Marked and sustained improvement one year after autologous peripheral blood stem cell transplant in a girl with severe progressive systemic sclerosis. Rev Rhum [Engl Ed], 64 (Suppl.), 248S (Abstract)
25. Messner RP (1997). The potential of bone marrow stem cell transplantation in the treatment of autoimmune diseases. J Rheumatol, 24, 819-821
26. Savolainen HA and Isomaki HA (1993). Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol, 20, 1201-1203